Tumour marker increased: Which Medications Cause It? (4,095 Reports Across 142 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Tumour marker increased has been reported as an adverse event with 142 different drugs in the FDA's FAERS database, with 4,095 total reports. 223 of these reports resulted in death.The drugs most commonly associated with Tumour marker increased are PALBOCICLIB, FULVESTRANT, and NIRAPARIB.
4,095
Total Reports
142
Drugs Involved
223
Deaths
688
Hospitalizations
63.6 yrs
Average Patient Age
86.2% / 13.8%
Female / Male
Which Drugs Cause Tumour marker increased Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| PALBOCICLIB | 817 | 0.9% | 23 | 86 | 9 |
| FULVESTRANT | 408 | 2.3% | 34 | 54 | 9 |
| NIRAPARIB | 356 | 1.7% | 9 | 74 | 9 |
| LETROZOLE | 343 | 1.1% | 28 | 31 | 13 |
| RIBOCICLIB | 317 | 1.1% | 37 | 61 | 13 |
| RUCAPARIB CAMSYLATE | 257 | 3.1% | 7 | 32 | 0 |
| CAPECITABINE | 228 | 0.4% | 15 | 39 | 2 |
| EVEROLIMUS | 228 | 0.6% | 13 | 45 | 6 |
| ELACESTRANT | 222 | 3.2% | 3 | 21 | 2 |
| OLAPARIB | 171 | 0.9% | 9 | 11 | 1 |
| ANASTROZOLE | 142 | 1.3% | 4 | 12 | 5 |
| EXEMESTANE | 124 | 1.2% | 2 | 20 | 2 |
| ZOLEDRONIC ACID | 124 | 0.4% | 5 | 13 | 4 |
| BEVACIZUMAB | 117 | 0.2% | 11 | 21 | 5 |
| TRASTUZUMAB | 108 | 0.2% | 3 | 25 | 0 |
| TAMOXIFEN | 106 | 1.2% | 18 | 8 | 1 |
| DENOSUMAB | 96 | 0.1% | 1 | 8 | 3 |
| PACLITAXEL | 80 | 0.1% | 4 | 8 | 0 |
| ALPELISIB | 75 | 0.9% | 2 | 8 | 2 |
| LENALIDOMIDE | 75 | 0.0% | 0 | 10 | 0 |